While, it is clear that grade II astrocytomas and oligodendrogliomas are very different from GBMs in terms of their molecular/genetic profiles, grade II gliomas are benign brain tumors and were selected as a reference to analyze GBM-specific TF networks. This evidence concerns the gene TF and benign neoplasm of brain.